(Q53537849)

15 May 2018

title

CD4 T-cell responses to combination antiretroviral therapy. (English)

1 reference

15 May 2018

main subject

anti-retroviral agent

0 references

author

Gary Maartens

series ordinal

1

1 reference

15 May 2018

Andrew Boulle

object named as

Andrew Boulle

series ordinal

2

0 references

language of work or name

English

0 references

publication date

1 August 2007

1 reference

15 May 2018

published in

The Lancet

1 reference

15 May 2018

volume

370

1 reference

15 May 2018

issue

9585

1 reference

15 May 2018

page(s)

366-368

1 reference

15 May 2018

Immunological recovery and antiretroviral therapy in HIV-1 infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960949-0

7 January 2021

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960949-0

7 January 2021

CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960949-0

7 January 2021

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960949-0

7 January 2021

Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960949-0

7 January 2021

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960949-0

7 January 2021

Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960949-0

7 January 2021

Low CD4+T Cell Nadir Is an Independent Predictor of Lower HIV‐Specific Immune Responses in Chronically HIV‐1–Infected Subjects Receiving Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960949-0

7 January 2021

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960949-0

7 January 2021

Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960949-0

7 January 2021

Accounting for leadtime in cohort studies: evaluating when to initiate HIV therapies.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2960949-0

7 January 2021

10.1016/S0140-6736(07)60949-0

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018